What is personalized medicine?

Personalized medicine is a modern approach to health care that uses your individual biology to find treatments that work best for you. Instead of the trial-and-error process — where you're prescribed something, wait weeks, and then maybe switch again — this method aims to get it right the first time.

Imagine two people with anxiety getting the same medication. One feels better, the other feels worse. Why? Because our bodies — and especially our brains — respond to medications differently. Personalized medicine uses your DNA, health history, lifestyle, and even your gut bacteria to predict which treatments will actually work for you.

What does it look at?

  • Genetics — variations in your genes (like CYP450) affect how fast you metabolize medications like antidepressants
  • Biomarkers — clues from your blood, saliva, or even microbiome that guide doctors on treatment options
  • Environment and lifestyle — stress levels, sleep habits, and nutrition are all factored into your care plan
  • Tech tools — AI and big data help doctors compare your profile to thousands of others to predict outcomes

An example

Say your friend tried Zoloft and it worked in a few weeks. You try it, and nothing. Personalized testing might have shown that your liver metabolizes Zoloft too quickly for it to help — another medication might have been a better fit from the start.

How it works

Genetic testing helps doctors find out how your body might react to different mental health medications. Step by step:

  1. Simple DNA collection. You give a small sample — a cheek swab or saliva — at your doctor's office or through a testing kit. Quick and painless.
  2. Genetic analysis. A lab copies the DNA using PCR, then scans it with microarrays or sequencing for changes in key genes like CYP2C19, CYP2D6, and SLC6A4 — genes that affect whether you break medications down too quickly, too slowly, or just right.
  3. Understanding your medication response. The results help predict whether you're more likely to have side effects, whether a medication might not work well, or whether you're likely to respond positively — skipping some of the trial and error.
  4. Personalized treatment planning. Your doctor combines your genetic results with sleep, lifestyle, and stress to build a plan that fits your biology.

Note: this testing doesn't look at your whole DNA — just the parts that affect mental health medications.

What this testing can and cannot tell you

This is worth separating carefully, because the two halves get run together and they are not the same claim.

How fast you process a drug is real, and it is narrow. Two liver enzymes, CYP2D6 and CYP2C19, break down many psychiatric medications, and people carry gene variants that make those enzymes work faster or slower. That has actual clinical guidance attached to it: the Clinical Pharmacogenetics Implementation Consortium publishes dosing recommendations by metabolizer status for specific antidepressants, including citalopram, escitalopram, sertraline, paroxetine and fluvoxamine. Where the evidence exists, the FDA puts this kind of information in a drug's own labeling.

Which medication will actually help you is a different question, and that is the contested one. Metabolism tells you about dose and about side-effect risk. It does not tell you which antidepressant will lift your depression. In 2018 the FDA warned the public about genetic tests claiming to predict response to specific medications where the claim was not supported by evidence, and in April 2019 it issued a warning letter to a genomics laboratory marketing tests that claimed to predict responses to antidepressants, opioids, cancer treatments, anaesthesia and diabetes medications. The FDA's concern was that such results could lead a clinician or a patient to change treatment when they should not. Several testing companies have since taken specific medication names out of their reports.

If someone offers you one of these tests

The useful question is not “is it accurate?” but what has it been shown to predict? A result about how quickly you metabolise a drug is on firmer ground than a result naming the medication you should take. Either way, do not start, stop or change a medication because of a test result on its own. That is a conversation with the person who prescribes for you.

Why this matters

  • Less guessing means quicker relief
  • Fewer side effects mean better quality of life
  • More informed decisions mean more power in your own care

In their words

  • “I didn't know my genes could affect which antidepressants work. It would've saved me so much time and pain.” — Jade, 21
  • “Personalized medicine made me feel seen. It gave me hope when I was running out of options.” — Luis, 20
  • “If I had known about this before, I wouldn't have gone through three meds that made me feel worse.” — Sarah, 22

Next steps

  • Curious if your medication matches your DNA? Ask your doctor or campus health provider about genetic testing tools like GeneSight or Genomind.
  • Share this page with a friend who might be struggling.

Disclosure

This page was created as part of an academic assignment for NST-104 (Biotechnology and Society) at Babson College. It is intended for educational purposes only, based on publicly available research, and is not medical advice. Please consult a licensed healthcare provider for personal recommendations about genetic testing and psychiatric medications.

Sources

  1. Hicks JK, Bishop JR, Sangkuhl K, et al. — Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors, Clinical Pharmacology & Therapeutics, 2015 (the dosing-by-metabolizer-status half)
  2. Bousman CA, Stevenson JM, Ramsey LB, et al. — Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants, Clinical Pharmacology & Therapeutics 114(1):51–68, 2023 (the current update, which adds CYP2B6 and concludes the pharmacodynamic genes SLC6A4 and HTR2A do not yet support clinical use)
  3. US Food and Drug Administration — FDA issues warning letter to genomics lab for illegally marketing genetic test that claims to predict patients’ responses to specific medications, 4 April 2019 (the contested half; the letter names antidepressants, opioids, cancer treatments, anaesthesia and diabetes medications)
  4. Conley, M. (2024) — Finding personalized approaches to treating mental illness, Stanford Medicine Magazine
  5. MedlinePlus Genetics — CYP2C19 gene, U.S. National Library of Medicine
  6. Maslej, M. M. et al. (2023) — Out with AI, in with the psychiatrist, Translational Psychiatry
  7. National Human Genome Research Institute — Personalized medicine, Genome.gov
  8. National Institute of Mental Health — Mental health medications
  9. Mayo Clinic — Pharmacogenomics in patient care

Sources were last checked September 2026. Every source links to the exact document cited, never a homepage.